published: true tags: kind:mechanism, section:mechanisms, state:published, evidence:strong editor: markdown pageId: 15242 dateCreated: “2026-03-19T13:44:19.122Z” dateUpdated: “2026-04-01T14:00:00.000Z” lastReviewed: “2026-04-01T14:00:00.000Z” refs: heneka2018: authors: Heneka MT, et al. title: Neuroinflammation in Parkinson’s disease journal: Lancet Neurology year: 2018 doi: 10.1016/S2213-2600(18)30069-2 pmid: 29371075 streit2012: authors: Streit WJ, et al. title: ‘Microglial pathology: I. When microglia go bad’ journal: Progress in Neurobiology year: 2012 doi: 10.1016/j.pneurobio.2012.05.001 kim2015: authors: Kim C, et al. title: Antagonizing neural toll-like receptor 2 prevents synucleinopathy by activating autophagy ^{1Mechanistic of LRRK2-Mediated Pyroptosis Via the NLRP3/Caspase-1/GSDMD Pathway in Parkinson's Disease Progression.2026 · Inflammation · DOI 10.1007/s10753-026-02475-w · PMID 41831074Open reference} journal: Cell Reports year: 2015 doi: 10.1016/j.celrep.2015.03.017 george2013: authors: George S, et al. title: ‘α-Synuclein: The long distance runner’ journal: Annals of Neurology year: 2013 doi: 10.1002/ana.24723 gordon2018: authors: Gordon R, et al. title: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice ^{2Exosomes Regulate the NLRP3/Caspase-1/IL-1β Signaling Pathway in Parkinson's Disease: Mechanisms of Neuroinflammation Modulation and α-Synuclein Propagation.2026 · Neuropsychiatric disease and treatment · DOI 10.2147/NDT.S587802 · PMID 41798290Open reference} journal: Nature Medicine year: 2018 doi: 10.1038/s41591-018-0053-5 liddelow2017: authors: Liddelow SA, et al. title: Neurotoxic reactive astrocytes are induced by activated microglia journal: Nature year: 2017 doi: 10.1038/nature21029 sulzer2017: authors: Sulzer D, et al. title: T cells from patients with Parkinson’s disease recognize α-synuclein peptides ^{3Lnc-USP28-6/ZBTB16 axis orchestrates NLRP3 inflammasome activation and α-synuclein SUMOylation to drive Parkinson's disease pathogenesis.2026 · Brain, behavior, and immunity · DOI 10.1016/j.bbi.2026.106510 · PMID 41775328Open reference} journal: Nature year: 2017 doi: 10.1038/nature22815 gray2013: authors: Gray MT, Woulfe JM title: Striatal blood-brain barrier permeability in Parkinson’s disease journal: Acta Neuropathol Commun year: 2013 doi: 10.1186/2051-5960-1-35 pmid: 24163339 sampson2016: authors: Sampson TR, et al. title: Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease journal: Cell year: 2016 doi: 10.1016/j.cell.2016.11.018 hirsch2009: authors: Hirsch EC, Hunot S title: ‘Neuroinflammation in Parkinson’‘s disease: a target for neuroprotection?’ journal: Lancet Neurology year: 2009 doi: 10.1016/S1474-4422(09)70130-4 pmid: 19592382 depboylu2012: authors: Depboylu C, et al. title: Deficient monocyte activation in Parkinson’s disease journal: PLoS ONE year: 2012 doi: 10.1371/journal.pone.0011431 lawson1990: authors: Lawson LJ, et al. title: Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain journal: Neuroscience year: 1990 doi: 10.1016/0304-3940(90)90128-C pmid: 1978681

Neuroinflammation in Parkinson’s Disease

Overview

Neuroinflammation in Parkinson’s Disease describes a key molecular or cellular mechanism implicated in neurodegenerative disease, including Alzheimer’s disease, dementia with lewy bodies, and multiple system atrophy. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer’s disease, Parkinson’s disease, and related disorders.

Chronic neuroinflammation is now recognized as a central pathogenic mechanism in Parkinson’s disease (PD), contributing to dopaminergic neuron degeneration in the substantia nigra through multiple interconnected pathways involving microglial activation, alpha-synuclein aggregation, and mitochondrial dysfunction. Unlike acute inflammation that resolves with healing, neuroinflammation in PD becomes self-perpetuating through feed-forward loops involving microglial activation, peripheral immune infiltration, and the innate immune response to misfolded α-synuclein. This page provides a comprehensive mechanistic overview of neuroinflammatory pathways in PD and their therapeutic implications.

graph TD
    subgraph "Initiation Triggers"
        alpha["Synalpha-Synuclein Aggregates<br/>Fibrils, Oligomers, LB debris"]
        M["itoDamMicroglial DAMPs<br/>mtDNA, ATP, Cardiolipin"]
        P["eriphPeripheral Inflammation<br/>LPS, Gut dysbiosis"]
        N["eurDeathNeuronal Death<br/>Release of DAMPs"]
    end

    subgraph "Pattern Recognition"
        T["LR2TLR2<br/>alpha-Syn receptor"]
        T["LR4TLR4<br/>LPS + alpha-Syn"]
        N["LRP3NLRP3 Inflammasome<br/>DAMP sensor"]
        R["AGERAGE<br/>AGE + alpha-Syn receptor"]
    end

    subgraph "Microglial Response"
        M1["M1 Phenotype<br/>Pro-inflammatory"]
        M2["M2 Phenotype<br/>Neuroprotective"]
        R["OSROS/RNS Production<br/>NO, Superoxide"]
        C["ytokinePro-inflammatory Cytokines<br/>TNF-alpha, IL-1beta, IL-6"]
        P["hagocytPhagocytosis<br/>Impaired clearance"]
    end

    subgraph "Peripheral Immune"
        B["BBBBB Breakdown<br/>Tight junction loss"]
        T["cellT Cell Infiltration<br/>CD4+, CD8+"]
        M["onoMonocyte Recruitment<br/>CCR2/CCL2 axis"]
        B["cellB Cell Activation<br/>Autoantibodies"]
    end

    subgraph "Neuronal Damage"
        N["igroSNSubstantia Nigra<br/>Dopaminergic neurons"]
        S["ynLossSynaptic Dysfunction<br/>TNF-alpha, IL-1beta effects"]
        O["xiStressOxidative Stress<br/>ROS from microglia"]
        M["itochMitochondrial Damage<br/>NO inhibition of ETC"]
        A["popApoptosis<br/>Caspase activation"]
    end

    alphaSyn  -->  TL["R2"]
    alphaSyn  -->  TL["R4"]
    alphaSyn  -->  RA["GE"]
    M["itoDam"]  -->  NLR["P3"]
    P["eriph"]  -->  TL["R4"]
    N["eurDeath"]  -->  TL["R2"]
    N["eurDeath"]  -->  NLR["P3"]

    TL["R2"]  -->  M1
    TL["R4"]  -->  M1
    NLR["P3"]  -->  C["ytokine"]
    RAGE  -->  M1

    M1  -->  R["OS"]
    M1  -->  C["ytokine"]
    M1 -.->|"Impaired in PD"| P["hagocyt"]
    M2 -.->|"Suppressed in PD"| N["igroSN"]

    P["eriph"]  -->  B["BB"]
    BBB  -->  T["cell"]
    BBB  -->  M["ono"]
    BBB  -->  B["cell"]

    T["cell"]  -->  N["igroSN"]
    M["ono"]  -->  M1
    C["ytokine"]  -->  S["ynLoss"]
    C["ytokine"]  -->  B["BB"]
    ROS  -->  O["xiStress"]
    O["xiStress"]  -->  M["itoch"]
    M["itoch"]  -->  A["pop"]
    S["ynLoss"]  -->  N["igroSN"]
    A["pop"]  -->  N["eurDeath"]

Microglial Biology in PD

Microglial Phenotypes

Microglia exist on a spectrum of activation states rather than binary M1/M2 polarization^{4Innate Immunity and Neurodegeneration.2019 · Annual review of medicine · DOI 10.1146/annurev-med-050715-104343 · PMID 29106805Open reference}:

Pro-inflammatory (Classical M1-like) Features:

• Morphology: Amoeboid, retracted processes

• Markers: CD68, CD86, MHC-II, iNOS

• Cytokines: TNF-α, IL-1β, IL-6, IL-12, IL-23

• Effector molecules: ROS (superoxide, H₂O₂), RNS (NO, peroxynitrite)

• Receptors: TLR2, TLR4, RAGE, P2X7

Neuroprotective (Alternative M2-like) Features:

• Morphology: Ramified, extended processes

• Markers: CD206, Arg1, Ym1, TGF-β

• Cytokines: IL-10, TGF-β

• Functions: Phagocytosis, debris clearance, trophic support

• Growth factors: BDNF, GDNF, IGF-1

PD-Specific Dysregulation:

• Chronic shift toward M1 phenotype

• Impaired M2 transition (failed resolution)

• Reduced phagocytic capacity despite activation

• Tonic (sustained) rather than phasic activation

Microglial Priming and Aging

With aging, microglia become “primed” — more reactive to stimuli with impaired resolution^{5The peripheral sensory nervous system in the vertebrate head: a gene regulatory perspective.2012 · Developmental biology · DOI 10.1016/j.ydbio.2012.06.028 · PMID 22790010Open reference}:

• Fractalkine signaling decline: Reduced CX3CR1 (microglial) / CX3CL1 (neuronal) anti-inflammatory signaling

• DAM (disease-associated microglia) phenotype: Upregulation of APOE, TREM2, CST7; downregulation of homeostatic genes (P2RY12, TMEM119)

• Senescent microglia: SASP (senescence-associated secretory phenotype) with chronic cytokine production

• Iron accumulation: Increased ferritin, labile iron pool → oxidative stress

α-Synuclein as a Microglial Activator

Extracellular α-synuclein activates microglia through multiple receptors^{6Molecular mechanisms regulating NLRP3 inflammasome activation.2016 · Cellular & molecular immunology · DOI 10.1038/cmi.2015.95 · PMID 26549800Open reference}:

Impaired α-Synuclein Clearance

Microglial phagocytosis of α-synuclein becomes impaired in PD^{7Addiction as a stress surfeit disorder.2014 · Neuropharmacology · DOI 10.1016/j.neuropharm.2013.05.024 · PMID 23747571Open reference}:

1. Overwhelming load: Excess α-syn exceeds clearance capacity

2. Autophagy dysfunction: Lysosomal degradation impaired

3. Oxidative damage: Microglial ROS damage phagocytic machinery

4. Age-related decline: Reduced phagocytic receptor expression

5. LRRK2 mutations: Impaired autophagy in microglia (increased LRRK2 kinase activity)

The NLRP3 Inflammasome in PD

The NLRP3 inflammasome is a cytosolic multiprotein complex that activates caspase-1, leading to IL-1β and IL-18 maturation^{8Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction.2019 · The Journal of clinical investigation · DOI 10.1172/JCI95693 · PMID 29400693Open reference}:

graph LR
    subgraph "Priming Signal"
        T["LR_TNFTLR/NF-kappaB<br/>TNF-alpha receptor"]
        N["LRP3_geneNLRP3 transcription<br/>Pro-IL-1beta synthesis"]
    end

    subgraph "Activation Signals"
        K["_effluxK+ Efflux<br/>P2X7, ATP, alpha-Syn"]
        L["ysosomeLysosomal Damage<br/>alpha-Syn phagocytosis"]
        M["itoROSMitochondrial ROS<br/>Complex I inhibition"]
        C["athepsinCathepsin B Release<br/>Lysosomal rupture"]
    end

    subgraph "Inflammasome Assembly"
        N["LRP3_sensNLRP3 Sensor"]
        A["SCASC Adaptor<br/>PYD-CARD"]
        C["asp1Caspase-1<br/>Active tetramer"]
    end

    subgraph "Effectors"
        I["L1bIL-1beta<br/>Mature"]
        I["L18IL-18<br/>Mature"]
        G["SDMDGasdermin D<br/>Pore formation"]
        P["yroptPyroptosis<br/>Inflammatory death"]
    end

    TLR_TNF  -->  NLRP3_gene
    NLRP3_gene  -->  NLRP3_sens

    K_efflux  -->  N["LRP3_sens Lysosome["]  -->  C["]athepsin"]
    C["athepsin"]  -->  N["LRP3_sens MitoROS"]  -->  NLRP3_sens

    NLRP3_sens  -->  A["SC"]
    ASC  -->  C["asp1"]

    C["asp1["]  -->  I["]L1b"]
    C["asp1["]  -->  I["]L18"]
    C["asp1["]  -->  GSD["]MD"]
    GSDMD  -->  P["yropt"]

Evidence for NLRP3 in PD:

• Elevated NLRP3, ASC, caspase-1 in PD substantia nigra

• alpha-Synuclein fibrils activate NLRP3 in microglia

• NLRP3-deficient mice are protected in MPTP and alpha-Syn models

• MCC950 (NLRP3 inhibitor) is neuroprotective in preclinical PD

Astrocyte Contributions

Reactive Astrogliosis in PD

Astrocytes respond to PD pathology with both protective and harmful effects^{9Neurotoxic reactive astrocytes are induced by activated microglia.2017 · Nature · DOI 10.1038/nature21029 · PMID 28099414Open reference}:

A1 Neurotoxic Astrocytes:

• Induced by microglial IL-1α, TNF-α, C1q

• Markers: C3, Serping1, Amigo2

• Lose neurotrophic functions (reduced GDNF, BDNF)

• Gain neurotoxic properties (complement, ROS)

• Abundant in PD substantia nigra

A2 Neuroprotective Astrocytes:

• Induced by ischemia, trauma

• Markers: S100A10, PTX3, Emp1

• Upregulate neurotrophic factors

• Promote tissue repair

PD-Specific Astrocyte Dysfunction:

• Reduced glutamate uptake (GLT-1/EAAT2 downregulation)

• Impaired metabolic support to neurons

• α-Synuclein accumulation in astrocytes

• Gap junction dysfunction (Cx43)

Peripheral Immune Involvement

T Cell Infiltration

CD4⁺ and CD8⁺ T cells infiltrate the substantia nigra in PD^{10Closed-loop brain training: the science of neurofeedback.2017 · Nature reviews. Neuroscience · DOI 10.1038/nrn.2016.164 · PMID 28003656Open reference}:

α-Synuclein-Specific T Cells:

• T cells recognizing α-syn epitopes (30-50% of PD patients)

• Clonal expansion of specific TCR sequences

• May precede motor symptoms (prodromal marker)

Blood-Brain Barrier Dysfunction

BBB integrity is compromised in PD

• Tight junction loss: Claudin-5, occludin, ZO-1 downregulation

• Vascular inflammation: VCAM-1, ICAM-1 upregulation

• Pericyte dysfunction: Reduced coverage, PDGF-BB signaling

• MMP activation: MMP-2/9 degrade basement membrane

• Cerebral endothelial activation: NF-κB, AP-1 signaling

Gut-Brain Axis

The gut-brain axis contributes to peripheral inflammation in PD^{2Exosomes Regulate the NLRP3/Caspase-1/IL-1β Signaling Pathway in Parkinson's Disease: Mechanisms of Neuroinflammation Modulation and α-Synuclein Propagation.2026 · Neuropsychiatric disease and treatment · DOI 10.2147/NDT.S587802 · PMID 41798290Open reference}0:

• Gut dysbiosis: Altered microbiome composition, reduced SCFA-producing bacteria

• Intestinal permeability: Leaky gut → LPS translocation

• Enteric glia activation: α-Syn accumulation in ENS

• Vagal pathway: Ascending α-Syn propagation

• Peripheral LPS: Activates systemic and central inflammation

Molecular Mediators

Cytokines and Chemokines

Reactive Oxygen and Nitrogen Species

Microglial ROS/RNS production directly damages neurons^{2Exosomes Regulate the NLRP3/Caspase-1/IL-1β Signaling Pathway in Parkinson's Disease: Mechanisms of Neuroinflammation Modulation and α-Synuclein Propagation.2026 · Neuropsychiatric disease and treatment · DOI 10.2147/NDT.S587802 · PMID 41798290Open reference}1:

• Superoxide (O₂•⁻): NOX2 activation, mitochondrial

• Hydrogen peroxide (H₂O₂): Dismutated from superoxide

• Hydroxyl radical (•OH): Fenton chemistry with iron

• Nitric oxide (NO): iNOS induction; inhibits Complex IV

• Peroxynitrite (ONOO⁻): NO + O₂•⁻; nitrates proteins

Complement System

Classical and alternative complement pathways are activated in PD^{2Exosomes Regulate the NLRP3/Caspase-1/IL-1β Signaling Pathway in Parkinson's Disease: Mechanisms of Neuroinflammation Modulation and α-Synuclein Propagation.2026 · Neuropsychiatric disease and treatment · DOI 10.2147/NDT.S587802 · PMID 41798290Open reference}2:

• C1q: Binds α-synuclein, marks synapses for removal

• C3: Opsonizes α-syn, promotes phagocytosis

• C5a: Activates microglia via C5aR1

• MAC (C5b-9): May form on neurons, sublethal damage

• Synaptic pruning: Excessive complement-mediated synapse elimination

Cell-Type Specific Vulnerability

The substantia nigra pars compacta (SNpc) is uniquely vulnerable to neuroinflammation^{2Exosomes Regulate the NLRP3/Caspase-1/IL-1β Signaling Pathway in Parkinson's Disease: Mechanisms of Neuroinflammation Modulation and α-Synuclein Propagation.2026 · Neuropsychiatric disease and treatment · DOI 10.2147/NDT.S587802 · PMID 41798290Open reference}3:

Therapeutic Targets and Strategies

Anti-inflammatory Approaches

Microglial Modulation

Shifting M1 → M2:

• Minocycline: Inhibits microglial activation (mixed results in trials)

• Ibuprofen: NSAID with microglial effects (epidemiological protection)

• PPARγ agonists (pioglitazone): Promote M2 phenotype (Phase II negative)

Enhancing Phagocytosis:

• TREM2 agonist antibodies

• Anti-α-synuclein immunotherapy (passive/active vaccines)

Targeting Peripheral Inflammation

• Gut microbiome: Probiotics, prebiotics, FMT

• Vagal stimulation: Reduces peripheral and central inflammation

• Exercise: Anti-inflammatory effects, increased BDNF

Biomarkers of Neuroinflammation in PD

See Also

• Alpha-Synuclein Aggregation

• Microglia

• Oxidative Stress — ROS production

• Mitochondrial Dysfunction — DAMP source

• Gut-Brain Axis in Tauopathy

External Links

• Allen Human Brain Atlas: Neuroinflammation in PD gene expression — Search for PD-related inflammation genes across brain regions

• Allen Cell Type Atlas: Cell type-specific RNA-seq — View microglial gene expression in Parkinson’s disease

• BrainSpan: Developmental transcriptome — Microglial gene expression across brain development

• PubMed

• KEGG Pathways

Related Hypotheses

From the SciDEX Exchange — scored by multi-agent debate

• Blood-Brain Barrier SPM Shuttle System — 0.75 · Target: TFRC

• Senescent Microglia Resolution via Maresins-Senolytics Combination — 0.72 · Target: BCL2L1

• Microglial Efferocytosis Enhancement via GPR32 Superagonists — 0.63 · Target: CMKLR1

• Circadian-Gated Maresin Biosynthesis Amplification — 0.60 · Target: ALOX12

• Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Therapy — 0.58 · Target: ALOX15

• Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution — 0.57 · Target: GPR37

• Mitochondrial SPM Synthesis Platform Engineering — 0.47 · Target: ALOX5

Related Analyses:

• Immune atlas neuroinflammation analysis in neurodegeneration 🔄

• Neuroinflammation resolution mechanisms and pro-resolving mediators 🔄

Pathway Diagram

The following diagram shows the key molecular relationships involving Neuroinflammation in PD discovered through SciDEX knowledge graph analysis:

graph TD
    entities_microglia_in_neurodeg["entities-microglia-in-neurodegeneration"] -->|"involved in"| neuroinflammation["neuroinflammation"]
    entities_complement_system["entities-complement-system"] -->|"involved in"| neuroinflammation["neuroinflammation"]
    TNF["TNF"] -->|"activates"| neuroinflammation["neuroinflammation"]
    autophagy["autophagy"] -->|"associated with"| neuroinflammation["neuroinflammation"]
    GFAP["GFAP"] -->|"associated with"| neuroinflammation["neuroinflammation"]
    TREM2["TREM2"] -->|"mediates"| neuroinflammation["neuroinflammation"]
    NLRP3["NLRP3"] -->|"promotes"| neuroinflammation["neuroinflammation"]
    NF__B["NF-κB"] -->|"activates"| neuroinflammation["neuroinflammation"]
    STING["STING"] -->|"promotes"| neuroinflammation["neuroinflammation"]
    DHT["DHT"] -.->|"inhibits"| neuroinflammation["neuroinflammation"]
    RIPK1["RIPK1"] -->|"regulates"| neuroinflammation["neuroinflammation"]
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"drives"| neuroinflammation["neuroinflammation"]
    DAMPs["DAMPs"] -->|"associated with"| neuroinflammation["neuroinflammation"]
    ACOD1["ACOD1"] -.->|"inhibits"| neuroinflammation["neuroinflammation"]
    cGAS_STING_NF__B_signaling["cGAS-STING-NF-κB signaling"] -->|"promotes"| neuroinflammation["neuroinflammation"]
    style entities_microglia_in_neurodeg fill:#4fc3f7,stroke:#333,color:#000
    style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
    style entities_complement_system fill:#4fc3f7,stroke:#333,color:#000
    style TNF fill:#4fc3f7,stroke:#333,color:#000
    style autophagy fill:#4fc3f7,stroke:#333,color:#000
    style GFAP fill:#4fc3f7,stroke:#333,color:#000
    style TREM2 fill:#ce93d8,stroke:#333,color:#000
    style NLRP3 fill:#4fc3f7,stroke:#333,color:#000
    style NF__B fill:#81c784,stroke:#333,color:#000
    style STING fill:#4fc3f7,stroke:#333,color:#000
    style DHT fill:#ff8a65,stroke:#333,color:#000
    style RIPK1 fill:#4fc3f7,stroke:#333,color:#000
    style mitochondrial_dysfunction fill:#4fc3f7,stroke:#333,color:#000
    style DAMPs fill:#ff8a65,stroke:#333,color:#000
    style ACOD1 fill:#ce93d8,stroke:#333,color:#000
    style cGAS_STING_NF__B_signaling fill:#81c784,stroke:#333,color:#000